• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.74% Nasdaq Up 0.92%

    Incyte Corporation (INCY)

    -NasdaqGS
    89.07 Up 0.31(0.35%) Sep 27, 4:00PM EDT
    |Pre-Market : 91.00 Up 1.93 (2.17%) 7:46AM EDT - Nasdaq Real Time Price
    Prev Close:88.76
    Open:88.56
    Bid:72.60 x 100
    Ask:107.00 x 400
    1y Target Est:98.71
    Beta:1.18664
    Earnings Date:Nov 1 - Nov 7 (Est.)
    Day's Range:86.91 - 89.24
    52wk Range:55.00 - 131.33
    Volume:1,219,571
    Avg Vol (3m):1,145,270
    Market Cap:16.75B
    P/E (ttm):242.04
    EPS (ttm):0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYUp 0.35%16.75B
    CELGUp 1.03%83.25B
    AMGNDown 1.09%128.44B

    Key Statistics

    Forward P/E (1 yr):65.49
    P/S (ttm):17.73
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :0.19
    Quarterly EPS Est (Sep-16) :-0.04
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):8.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback